We have located links that may give you full text access.
Pupillary response to emotional stimuli as a risk factor for depressive symptoms following a natural disaster: The 2011 Binghamton flood.
Understanding pathways of risk following a natural disaster may help create next-generation targeted interventions. The current study examined if a biomarker of cognitive-affective response (pupil dilation) could identify which individuals are at greatest risk for depression following disaster-related stress. Fifty-one women completed a computer-based task assessing pupillary response to facial expressions of emotion and reported their depressive symptoms before the 2011 Binghamton flood. Following the flood, women were assessed for objective levels of flood-related stress and again reported their depressive symptoms. Supporting the proposed diathesis-stress model, decreased pupil dilation to emotional expressions predicted a significant increase in post-flood depressive symptoms, but only among women who experienced higher levels of flood-related stress. Findings suggest that reduced cognitive-affective response to emotional stimuli (measured via pupillary response) can increase risk for depression in the context of high levels of objective life stress.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app